Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fphar.2020.00950 http://scihub22266oqcxt.onion/10.3389/fphar.2020.00950 32670066!7327107!32670066     free     free     free       Front+Pharmacol 2020 ; 11 (ä): 950 Nephropedia Template TP {{tp|p=32670066|t=2020. Pharmacotherapics Advice in Guidelines for COVID-19 |pdf=|usr=}}{{32670066}} gab.com Text Pharmacotherapics Advice in Guidelines for COVID-19 JO: Front Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=32670066 #FOAvip Since December 2019 to May 2020, coronavirus disease 2019 (COVID-19) has infected over 6 million people worldwide. Due to its sudden and rapid outbreak, effective treatment for COVID-19 is scarce. Based on national clinical trials of novel treatments, China, Italy, Germany, and other countries and organizations have published multiple guidelines for COVID-19 and advised many medicines, such as chloroquine and tocilizumab. In this paper, we summarize the pharmacotherapy for COVID-19 according to those guidelines, highlight updates of the pharmacotherapy guidelines, and review the efficacy and safety of the indicated anti-COVID-19 drugs. Twit Text FOAVip Pharmacotherapics Advice in Guidelines for COVID-19 ????Front Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=32670066 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32670066 #FOAvip English Wikipedia <ref>{{Cite pmid|32670066}}</ref> Pharmacotherapics Advice in Guidelines for COVID-19 #MMPMID32670066 Chen ZR; Zhou Y; Liu J; Peng HW; Zhou J; Zhong HL; Liu LL; Lai MF; Wei XH; Wen JH Front Pharmacol 2020[]; 11 (ä): 950 PMID32670066show ga Since December 2019 to May 2020, coronavirus disease 2019 (COVID-19) has infected over 6 million people worldwide. Due to its sudden and rapid outbreak, effective treatment for COVID-19 is scarce. Based on national clinical trials of novel treatments, China, Italy, Germany, and other countries and organizations have published multiple guidelines for COVID-19 and advised many medicines, such as chloroquine and tocilizumab. In this paper, we summarize the pharmacotherapy for COVID-19 according to those guidelines, highlight updates of the pharmacotherapy guidelines, and review the efficacy and safety of the indicated anti-COVID-19 drugs. äPharmacotherapics Advice in Guidelines for COVID-19 (epmc).pdf DeepDyve Pubget Overpricing